India ill prepared despite lessons learnt in the first wave
Precious time was wasted before critical facilities began to be scaled up to meet the demands of the second wave that is accelerating at an unprecedented speed leading to healthcare…
Category: Remdesivir
How the new coronavirus variant quickly accumulated 17 mutations
According to a preliminary report posted on December 19 by the COG-UK Consortium scientists, as of December 15, 1,623 variant genomes have been sequenced. In a December 21 tweet, COG-UK…
WHO supported Solidarity trial finds remdesivir ineffective but WHO prequalifies it anyway
Even as WHO supported Solidarity Therapeutics Trial found remdesivir to be ineffective in reducing mortality and duration of hospital stay, the global body prequalified the drug the same day the…
Remdesivir, other repurposed drugs ineffective, says WHO’s Solidarity trial
WHO’s Solidarity Therapeutics Trial, the largest randomised control trial carried out in the world during the pandemic, has found that four repurposed drugs — remdesivir, interferon, hydroxychloroquine and lopinavir/ritonavir regimes…
Gilead to begin testing inhaled remdesivir for early-stage treatment
Gilead plans to begin a Phase-1 clinical trial in August of an inhaled version of remdesivir for early-stage COVID-19 treatment outside of hospital settings. The drug is currently approved for…
Remdesivir drug has no significant clinical benefits for COVID-19 patients: Lancet
Treating severe COVID-19 patients with the antiviral drug remdesivir does not quicken recovery, the first randomised, placebo-controlled, double-blind trial found. Although not statistically significant, those treated with the drug within…
